Nucleic acid binding, RNA binding
Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 19 |
NetGPI | no | yes: 0, no: 19 |
Term | Name | Level | Count |
---|---|---|---|
GO:0020022 | acidocalcisome | 5 | 1 |
GO:0043226 | organelle | 2 | 1 |
GO:0043227 | membrane-bounded organelle | 3 | 1 |
GO:0043229 | intracellular organelle | 3 | 1 |
GO:0043231 | intracellular membrane-bounded organelle | 4 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 2 |
GO:0016020 | membrane | 2 | 1 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pescher et al. (upgregulation) | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Lahav et al. - mRNA
- Protein
|
Related structures:
AlphaFold database: A4HY39
Term | Name | Level | Count |
---|---|---|---|
GO:0005488 | binding | 1 | 14 |
GO:0043167 | ion binding | 2 | 13 |
GO:0043169 | cation binding | 3 | 13 |
GO:0046872 | metal ion binding | 4 | 13 |
GO:0003824 | catalytic activity | 1 | 1 |
GO:0004842 | ubiquitin-protein transferase activity | 4 | 1 |
GO:0016740 | transferase activity | 2 | 1 |
GO:0019787 | ubiquitin-like protein transferase activity | 3 | 1 |
GO:0140096 | catalytic activity, acting on a protein | 2 | 1 |
GO:0003676 | nucleic acid binding | 3 | 1 |
GO:0003723 | RNA binding | 4 | 1 |
GO:0097159 | organic cyclic compound binding | 2 | 1 |
GO:1901363 | heterocyclic compound binding | 2 | 1 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 144 | 146 | PF00675 | 0.433 |
CLV_NRD_NRD_1 | 39 | 41 | PF00675 | 0.476 |
CLV_NRD_NRD_1 | 71 | 73 | PF00675 | 0.525 |
CLV_NRD_NRD_1 | 88 | 90 | PF00675 | 0.538 |
CLV_PCSK_KEX2_1 | 144 | 146 | PF00082 | 0.374 |
CLV_PCSK_KEX2_1 | 39 | 41 | PF00082 | 0.502 |
CLV_PCSK_KEX2_1 | 71 | 73 | PF00082 | 0.468 |
CLV_PCSK_KEX2_1 | 88 | 90 | PF00082 | 0.478 |
CLV_PCSK_SKI1_1 | 164 | 168 | PF00082 | 0.681 |
DEG_Nend_UBRbox_3 | 1 | 3 | PF02207 | 0.593 |
DOC_CYCLIN_RxL_1 | 37 | 47 | PF00134 | 0.326 |
DOC_MAPK_MEF2A_6 | 210 | 219 | PF00069 | 0.478 |
DOC_MAPK_MEF2A_6 | 244 | 253 | PF00069 | 0.397 |
DOC_MAPK_MEF2A_6 | 39 | 46 | PF00069 | 0.327 |
DOC_MAPK_NFAT4_5 | 39 | 47 | PF00069 | 0.326 |
DOC_USP7_MATH_1 | 186 | 190 | PF00917 | 0.638 |
DOC_USP7_MATH_1 | 332 | 336 | PF00917 | 0.629 |
DOC_USP7_MATH_1 | 342 | 346 | PF00917 | 0.614 |
DOC_USP7_UBL2_3 | 119 | 123 | PF12436 | 0.522 |
DOC_USP7_UBL2_3 | 367 | 371 | PF12436 | 0.598 |
DOC_WW_Pin1_4 | 14 | 19 | PF00397 | 0.496 |
DOC_WW_Pin1_4 | 2 | 7 | PF00397 | 0.508 |
LIG_14-3-3_CanoR_1 | 282 | 292 | PF00244 | 0.473 |
LIG_14-3-3_CanoR_1 | 39 | 43 | PF00244 | 0.544 |
LIG_FHA_1 | 14 | 20 | PF00498 | 0.542 |
LIG_FHA_1 | 22 | 28 | PF00498 | 0.456 |
LIG_FHA_2 | 127 | 133 | PF00498 | 0.389 |
LIG_FHA_2 | 284 | 290 | PF00498 | 0.521 |
LIG_GBD_Chelix_1 | 44 | 52 | PF00786 | 0.390 |
LIG_LIR_Gen_1 | 57 | 64 | PF02991 | 0.499 |
LIG_LIR_Nem_3 | 262 | 268 | PF02991 | 0.347 |
LIG_LIR_Nem_3 | 57 | 62 | PF02991 | 0.500 |
LIG_LIR_Nem_3 | 68 | 73 | PF02991 | 0.504 |
LIG_LRP6_Inhibitor_1 | 272 | 278 | PF00058 | 0.339 |
LIG_NRBOX | 145 | 151 | PF00104 | 0.460 |
LIG_PTB_Apo_2 | 264 | 271 | PF02174 | 0.354 |
LIG_PTB_Phospho_1 | 264 | 270 | PF10480 | 0.373 |
LIG_SH2_CRK | 234 | 238 | PF00017 | 0.476 |
LIG_SH2_CRK | 59 | 63 | PF00017 | 0.395 |
LIG_SH2_CRK | 70 | 74 | PF00017 | 0.373 |
LIG_SH2_GRB2like | 299 | 302 | PF00017 | 0.486 |
LIG_SH2_SRC | 90 | 93 | PF00017 | 0.474 |
LIG_SH2_STAP1 | 270 | 274 | PF00017 | 0.359 |
LIG_SH2_STAP1 | 8 | 12 | PF00017 | 0.387 |
LIG_SH2_STAT3 | 125 | 128 | PF00017 | 0.489 |
LIG_SH2_STAT5 | 103 | 106 | PF00017 | 0.473 |
LIG_SH2_STAT5 | 113 | 116 | PF00017 | 0.371 |
LIG_SH3_3 | 153 | 159 | PF00018 | 0.626 |
LIG_SH3_3 | 171 | 177 | PF00018 | 0.443 |
LIG_SH3_3 | 291 | 297 | PF00018 | 0.538 |
LIG_SH3_3 | 90 | 96 | PF00018 | 0.346 |
LIG_TRAF2_1 | 129 | 132 | PF00917 | 0.411 |
MOD_CK1_1 | 126 | 132 | PF00069 | 0.444 |
MOD_CK1_1 | 315 | 321 | PF00069 | 0.554 |
MOD_CK1_1 | 345 | 351 | PF00069 | 0.738 |
MOD_CK1_1 | 372 | 378 | PF00069 | 0.617 |
MOD_CK2_1 | 126 | 132 | PF00069 | 0.387 |
MOD_CK2_1 | 283 | 289 | PF00069 | 0.520 |
MOD_CK2_1 | 352 | 358 | PF00069 | 0.684 |
MOD_CK2_1 | 44 | 50 | PF00069 | 0.425 |
MOD_GlcNHglycan | 188 | 191 | PF01048 | 0.607 |
MOD_GlcNHglycan | 227 | 231 | PF01048 | 0.579 |
MOD_GlcNHglycan | 314 | 317 | PF01048 | 0.587 |
MOD_GlcNHglycan | 347 | 350 | PF01048 | 0.639 |
MOD_GlcNHglycan | 379 | 382 | PF01048 | 0.703 |
MOD_GSK3_1 | 108 | 115 | PF00069 | 0.452 |
MOD_GSK3_1 | 119 | 126 | PF00069 | 0.457 |
MOD_GSK3_1 | 2 | 9 | PF00069 | 0.437 |
MOD_GSK3_1 | 23 | 30 | PF00069 | 0.543 |
MOD_GSK3_1 | 97 | 104 | PF00069 | 0.387 |
MOD_N-GLC_1 | 139 | 144 | PF02516 | 0.381 |
MOD_N-GLC_1 | 332 | 337 | PF02516 | 0.666 |
MOD_NEK2_1 | 27 | 32 | PF00069 | 0.468 |
MOD_NEK2_1 | 283 | 288 | PF00069 | 0.524 |
MOD_NEK2_1 | 44 | 49 | PF00069 | 0.389 |
MOD_OFUCOSY | 281 | 287 | PF10250 | 0.509 |
MOD_PIKK_1 | 123 | 129 | PF00454 | 0.358 |
MOD_PIKK_1 | 21 | 27 | PF00454 | 0.522 |
MOD_PIKK_1 | 332 | 338 | PF00454 | 0.513 |
MOD_PKA_2 | 345 | 351 | PF00069 | 0.543 |
MOD_PKA_2 | 38 | 44 | PF00069 | 0.541 |
MOD_Plk_1 | 108 | 114 | PF00069 | 0.475 |
MOD_Plk_1 | 139 | 145 | PF00069 | 0.401 |
MOD_Plk_1 | 261 | 267 | PF00069 | 0.372 |
MOD_Plk_2-3 | 101 | 107 | PF00069 | 0.375 |
MOD_Plk_4 | 27 | 33 | PF00069 | 0.549 |
MOD_ProDKin_1 | 14 | 20 | PF00069 | 0.490 |
MOD_ProDKin_1 | 2 | 8 | PF00069 | 0.509 |
MOD_SUMO_for_1 | 389 | 392 | PF00179 | 0.645 |
MOD_SUMO_rev_2 | 111 | 120 | PF00179 | 0.485 |
MOD_SUMO_rev_2 | 75 | 80 | PF00179 | 0.503 |
TRG_DiLeu_BaLyEn_6 | 162 | 167 | PF01217 | 0.414 |
TRG_ENDOCYTIC_2 | 59 | 62 | PF00928 | 0.361 |
TRG_ENDOCYTIC_2 | 70 | 73 | PF00928 | 0.369 |
TRG_ENDOCYTIC_2 | 90 | 93 | PF00928 | 0.380 |
TRG_ER_diArg_1 | 143 | 145 | PF00400 | 0.422 |
TRG_ER_diArg_1 | 38 | 40 | PF00400 | 0.495 |
TRG_ER_diArg_1 | 70 | 72 | PF00400 | 0.527 |
TRG_ER_diArg_1 | 87 | 89 | PF00400 | 0.515 |
TRG_ER_diLys_1 | 388 | 392 | PF00400 | 0.670 |
TRG_NES_CRM1_1 | 148 | 160 | PF08389 | 0.589 |
TRG_NES_CRM1_1 | 37 | 50 | PF08389 | 0.513 |
TRG_Pf-PMV_PEXEL_1 | 112 | 116 | PF00026 | 0.451 |
TRG_Pf-PMV_PEXEL_1 | 144 | 148 | PF00026 | 0.388 |
TRG_Pf-PMV_PEXEL_1 | 71 | 75 | PF00026 | 0.422 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1I1I4 | Leptomonas seymouri | 70% | 99% |
A0A0N1PG85 | Leptomonas seymouri | 32% | 100% |
A0A0S4KEK3 | Bodo saltans | 37% | 100% |
A0A1X0P6E1 | Trypanosomatidae | 36% | 100% |
A0A3Q8IA61 | Leishmania donovani | 31% | 100% |
A0A3R7RSV6 | Trypanosoma rangeli | 34% | 100% |
A0A3S7WVD2 | Leishmania donovani | 99% | 100% |
A0A422P3A2 | Trypanosoma rangeli | 40% | 96% |
A4H9Y7 | Leishmania braziliensis | 32% | 100% |
A4H9Y8 | Leishmania braziliensis | 74% | 100% |
A4HY52 | Leishmania infantum | 31% | 100% |
D0A0F3 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 34% | 100% |
D0A0F7 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 42% | 91% |
E9ARY1 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 31% | 99% |
E9ARY2 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 94% | 100% |
Q4QDJ1 | Leishmania major | 30% | 99% |
V5BSB1 | Trypanosoma cruzi | 37% | 82% |
V5BWY8 | Trypanosoma cruzi | 33% | 100% |